menu title
Screening and Treatment of HPV Lesions to Reduce Anal Cancer
-
Presentation Downloads:Related Documents:Related Links:
Presentation Details:
Presented by:
Jeffrey T. Schouten, MD, JD
Director of the Anal Dysplasia Clinic,
Harborview Medical Center
Clinical Investigator,
University of Washington Positive Research
Clinical Associate Professor of Surgery Emeritus,
University of Washington
Clinical Associate Professor of Medicine Emeritus,
Division of Allergy and Infectious Diseases,
University of Washington
Objectives:
- Understand the association of high-risk HPV infection and the risk of anal cancer.
- Appreciate how anal cytology and high resolution anoscopy (HRA) is performed and how to diagnose high grade squamous intraepithelial lesions (HSIL).
- Review the findings of the ANCHOR study which showed a 57% decrease in the incidence of anal cancer in people living with HIV by treating HSIL.
- Understand the different screening options for anal HSIL
Presented by:
Jeffrey T. Schouten, MD, JD
Director of the Anal Dysplasia Clinic,
Harborview Medical Center
Clinical Investigator,
University of Washington Positive Research
Clinical Associate Professor of Surgery Emeritus,
University of Washington
Clinical Associate Professor of Medicine Emeritus,
Division of Allergy and Infectious Diseases,
University of Washington
Objectives:
- Understand the association of high-risk HPV infection and the risk of anal cancer.
- Appreciate how anal cytology and high resolution anoscopy (HRA) is performed and how to diagnose high grade squamous intraepithelial lesions (HSIL).
- Review the findings of the ANCHOR study which showed a 57% decrease in the incidence of anal cancer in people living with HIV by treating HSIL.
- Understand the different screening options for anal HSIL
Presentation Transcript: